Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection.
about
Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical ResearchHypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infectionIn vivo administration of a JAK3 inhibitor during acute SIV infection leads to significant increases in viral load during chronic infectionNK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaquesResidual immune dysregulation syndrome in treated HIV infection.Regulation of intestinal health and disease by innate lymphoid cellsMucosal immunity in human and simian immunodeficiency lentivirus infectionsLoss and dysregulation of Th17 cells during HIV infection.Immune activation and HIV persistence: implications for curative approaches to HIV infection.Progression to AIDS in SIV-Infected Rhesus Macaques is Associated with Distinct KIR and MHC class I Polymorphisms and NK Cell Dysfunction.HIV-associated chronic immune activation.Relationships between IL-17(+) subsets, Tregs and pDCs that distinguish among SIV infected elite controllers, low, medium and high viral load rhesus macaques.In vivo administration of a JAK3 inhibitor to chronically siv infected rhesus macaques leads to NK cell depletion associated with transient modest increase in viral loads.The secretion of IL-22 from mucosal NKp44⁺ NK cells is associated with microbial translocation and virus infection in SIV/SHIV-infected Chinese macaquesEnhancement of Microbiota in Healthy Macaques Results in Beneficial Modulation of Mucosal and Systemic Immune Function.Effects of Fecal Microbial Transplantation on Microbiome and Immunity in Simian Immunodeficiency Virus-Infected MacaquesPlasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion.NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy.Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease.SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosaMicrobial translocation, immune activation, and HIV disease.Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection.Microbial translocation in the pathogenesis of HIV infection and AIDS.Failure recovery of circulating NKG2D(+)CD56(dim)NK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrenceRate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaquesSuppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection.Mucosal immunology of HIV infection.IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaquesAntiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques.Estimating the contribution of the gut to plasma viral load in early SIV infectionProbiotics Differently Affect Gut-Associated Lymphoid Tissue Indolamine-2,3-Dioxygenase mRNA and Cerebrospinal Fluid Neopterin Levels in Antiretroviral-Treated HIV-1 Infected Patients: A Pilot Study.Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge.Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity.NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpointMicrobial translocation in HIV infection: causes, consequences and treatment opportunities.Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry.Targeting the gastrointestinal tract to develop novel therapies for HIV.HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication.
P2860
Q26765018-76624385-DB0A-4218-A5FC-EB2E333069EDQ27322468-0FF8F798-A159-4CD1-892E-C97233EA1DCFQ27330386-AD654738-DBED-47B5-B8B8-3B98378C5404Q33851763-93319E76-C5B1-4DBB-A53B-213FD96998CEQ34020121-F019AEC8-08F1-4A62-A268-0DD8E108B670Q34081391-8EF98AC3-1CFD-4880-B420-A15C87EE40C3Q34131265-7D9A2A0E-DB5D-43CA-B2A1-847F7D0B4D9EQ34350569-F06927B8-2849-453C-A68D-8779CFD1C368Q34351320-5FA5E785-2DA1-4D66-BB63-C712D0968C69Q34583325-FBBC59FB-4A90-4A43-81EB-313924BD0542Q34653277-5F61535A-F3B2-4830-B8B0-FBEBB41C08CEQ34688715-E4ED76DB-D066-479F-B8A5-60AE37B17076Q34907640-6CA4EFDC-8A06-424C-87B3-F01BACA3B7CEQ35155994-2968924B-E9AE-4C8C-A74D-95EF12284F35Q35908830-E3F7EC4C-08EE-4451-9EF7-A93BD1F53D87Q35943919-F0B07247-CC4E-44AE-B039-8296036D822AQ36106065-8505D678-6855-409D-9229-BED51AE1648CQ36140156-97ECD79C-D7EF-4B86-9410-ADBBAA936AE9Q36237445-BAB7F677-7EC0-40B0-AC78-4B9F4478F924Q36372127-C23C6B4F-3473-40CF-BFCC-411F4F9879C1Q36390314-3D67D0AA-2105-4510-A44F-C7FD93327ECEQ36486814-961D945E-01B2-47AB-9CAC-D2261BE06A9BQ36501286-D9EC42FA-4759-402F-817D-597681D771C7Q36516875-A282038F-1EB4-4202-8B7E-67C613138BEDQ36558287-8A579823-CA97-4421-8143-EF3C7CB67458Q36597366-7455DC8A-4FF1-4B55-A3B5-469E41F1FE39Q36881002-576EB846-E929-4D23-89AC-D883AD804724Q36911659-B7BAE257-772B-4927-B55A-24D6FF48A071Q36957775-33F69BB8-4CCA-4BB2-BCA5-59C133E7F67FQ36985422-54C167D0-984C-4A45-926C-BC8087B411B2Q37225169-8AF12FA6-06CA-4A42-9349-0CB6FA8A583AQ37371967-5B25952C-9A92-4C6D-8242-C6F5CA1A8503Q37377261-25344836-5517-4E8D-A301-56F2151374A1Q37400356-A68AD6C2-8262-43DC-BB86-796F7B8081B2Q37568931-9DC20A86-7763-497B-A7A2-6EE1CAE162B0Q37688634-18F475E7-ED06-4F5A-AF20-AAEFA5974854Q38034068-0F8BEFE9-EA5A-4137-9F9C-406FCCAA8277Q38369341-4992B7EF-488F-4DF1-9F7E-64569A9EE522Q38548095-62CD8B0D-503C-417A-BED6-CA7698A5F22CQ38780964-B306CABF-4FD9-4587-8CAE-B389DBE90F48
P2860
Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Gut inflammation and indoleami ...... NK cells during SIV infection.
@ast
Gut inflammation and indoleami ...... NK cells during SIV infection.
@en
type
label
Gut inflammation and indoleami ...... NK cells during SIV infection.
@ast
Gut inflammation and indoleami ...... NK cells during SIV infection.
@en
prefLabel
Gut inflammation and indoleami ...... NK cells during SIV infection.
@ast
Gut inflammation and indoleami ...... NK cells during SIV infection.
@en
P2093
P2860
P1433
P1476
Gut inflammation and indoleami ...... NK cells during SIV infection.
@en
P2093
Angela Carville
Fay E Wong
Jacqueline Gillis
Michelle Connole
Premeela A Rajakumar
R Keith Reeves
R Paul Johnson
Tristan I Evans
Yury V Kuzmichev
P2860
P304
P356
10.1182/BLOOD-2011-04-347260
P407
P577
2011-07-26T00:00:00Z